Posted in M&A / Deals Cumberland to sell drug portfolio to Apotex for $100m April 24, 2026 Pharmaceutical Business Review Under the agreement, Apotex will acquire Cumberland’s branded medicines for cash, subject to approval by Cumberland’s shareholders. M&A / DealsRead full story